i(3)so3-galactosylceramide and Glomerulonephritis

i(3)so3-galactosylceramide has been researched along with Glomerulonephritis* in 5 studies

Reviews

1 review(s) available for i(3)so3-galactosylceramide and Glomerulonephritis

ArticleYear
Role of selectins in glomerulonephritis.
    Clinical and experimental immunology, 2002, Volume: 129, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Cell Adhesion; Chemotaxis, Leukocyte; Chimera; Endothelium, Vascular; Glomerulonephritis; Humans; Hydroxyeicosatetraenoic Acids; Kidney Glomerulus; Lipoxins; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Mice, Knockout; Oligosaccharides; Rats; Rats, Inbred WKY; Rats, Wistar; Selectins; Sulfoglycosphingolipids

2002

Other Studies

4 other study(ies) available for i(3)so3-galactosylceramide and Glomerulonephritis

ArticleYear
Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:2

    In an attempt to explore a novel therapeutic approach, a new synthetic sulfatide derivative (SKK60037) was evaluated in an acute rat model of P-selectin and leukocyte-dependent thrombotic glomerulonephritis (TG). In vitro, SKK60037 inhibits the function of P- and L-selectin more effectively than sialyl Lewis X (sLe(x)), a well-established selectin blocker. TG was induced by the intravenous administration of nephrotoxic globulin (NTG) to rats pretreated with a subclinical dose of lipopolysaccharide. In this model, platelet accumulation was remarkable within 10 minutes after induction of disease, followed by the infiltration of leukocytes, mainly neutrophils and macrophages. Thrombus formation and fibrinogen deposition in the glomeruli were observed within 1 hour, and they proceeded until 6 hours. P-selectin was highly expressed in glomeruli, whereas E-selectin and L-selectin ligands were not detected. We tested the effects of SKK60037 in this model in comparison with sLe(x) and antirat P-selectin monoclonal antibody (ARP2-4). SKK60037 blocked platelet accumulation in glomerular capillaries at 10 minutes after NTG injection. At 6 hours, leukocyte infiltration and thrombosis were significantly suppressed. Protective effects of SKK60037 were similar to those of ARP2-4, whereas sLe(x) showed minimum effect. The superior effects and more favorable characteristics of SKK60037 to sLe(x) suggest the potential of SKK60037 for clinical application.

    Topics: Animals; Cell Adhesion Molecules; Female; Globulins; Glomerulonephritis; Kidney; Kidney Glomerulus; Lipopolysaccharides; Oligosaccharides; Rats; Rats, Wistar; Selectins; Sialyl Lewis X Antigen; Sulfoglycosphingolipids; Thrombosis

2001
Serum immunoglobulins in Heymann's experimental nephritis modulate binding of properdin and factor-H to sulpho-glycosphingolipids II3SO3(-)-Gg3Cer and III3SO3(-)-,II3SO3(-)-Gg3Cer.
    Journal of biochemistry, 1994, Volume: 116, Issue:2

    The nephropathic effects of Heymann's experimental nephrites involve autoallergic serum antibodies directed against rat kidney membrane constituents. In assessing the action of glycolipids as possible autoallergens in these conditions, it was found that heterologous and autologous Heymann's nephritis sera antibodies recognize that rat kidney sulphatides, II3SO3(-)-Gg3Cer (Stri1), and III3SO3(-)-,II3SO3(-)-Gg3Cer (Stri2). Two antibody populations in Heymann's sera, each reacting with only one of the two sulphatides, could be observed. It was further shown that human factor-H and properdin, pivotal regulators of the alternative pathway of complement activation, both bound to Stri2 in vitro. This binding of factor-H and properdin was differentially affected by affinity-purified anti-Stri2 antibodies of Heymann's nephritis sera. Whereas the interaction between factor-H and Stri2 was inhibited by the antibody, that of properdin was enhanced.

    Topics: Animals; Antibodies; Complement Activation; Complement Factor H; Complement Pathway, Alternative; Female; Glomerulonephritis; Glycolipids; Immunoglobulins; Male; Properdin; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Sulfoglycosphingolipids

1994
[Regional distribution of sulfatide in human kidney, and anti-sulfatide antibodies in sera from patients with nephritis detected by TLC immunostaining].
    Nihon Jinzo Gakkai shi, 1991, Volume: 33, Issue:7

    Glycolipids were isolated from lipid extract of human kidney. The major neutral glycolipids have been identified as ceramide monohexoside (CMH), ceramide dihexoside (CDH), ceramide trihexoside (CTH), and globoside. As the major acidic glycolipids, Gal Cer sulfate (sulfatide), Lac Cer sulfate, GM3, sialosyl paragloboside, GD3, and disialosyl paragloboside were identified and the most abundant component was sulfatide. Sulfatide was 2 times more concentrated in medulla compared to cortex. In addition, the localization of sulfatide antigen was determined in renal sections by immunoperoxidase staining method. Strong positive staining with sulfatide was observed in distal tubules, limbs of Henle's loop and collecting tubules of normal tissue, whereas glomeruli were negative of staining. However, positive results of glomerular epithelial cells occurred in FSGS and IgA nephropathy so far. Acidic fraction of lipid extract were chromatographed and then tested for antigen by immunostaining. Sera from patients with nephritis contain antibodies to the sulfatides of human kidney as determined by the direct binding of antibody to thin-layer chromatograms. These results suggest that sulfatide antigen may play important role in the occurrence and aggravation of glomerular diseases.

    Topics: Antibodies; Chromatography, Thin Layer; Glomerulonephritis; Glycolipids; Humans; Kidney; Sulfoglycosphingolipids

1991
[The role of sulfatides in autoimmunity in children with various glomerular disease].
    Nihon Jinzo Gakkai shi, 1991, Volume: 33, Issue:11

    Previous studies have suggested that autoimmunity to a number of kidney antigens may exist in glomerular disease. Our own work suggested that sulfatide which is one of the major acidic glycolipids of human kidney may be antigenic. Glycolipids were isolated from lipid extract of human kidney using thin-layer chromatography (TLC). As the major acidic glycolipids, sulfatide, CDH-sulfate, GM3, GD3 were identified. Acidic fraction of lipid extract were chromatographed and then tested for antigen by immunostaining. Sera from patients with IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis (HSPN) contained antibody to the sulfatide of human kidney as determined by the direct binding of antibody to TLC. In addition, we measured the presence of sulfatide antibodies by enzyme linked immunosorbent assay (ELISA) in sera of patients with various glomerular disease: IgAN, HSPN, mesangial proliferative glomerulonephritis, membranoproliferative glomerulonephritis (MPGN), focal and segmental glomeruosclerosis (FSGS), membranous nephropathy (MN), minimal change nephrotic syndrome (MCNS), acute post streptococcal glomerulonephritis (PSAGN), and lupus nephritis (LN). IgM class sulfatide antibody were demonstrated in many cases of them. The incidence of IgA class sulfatide antibody in HSPN and IgAN was significantly high, and also the high incidence of IgG class sulfatide antibody occurred in IgAN. On the other hand, we evaluated cellular hypersensitivity to sulfatide in IgAN, HSPN, and FSGS using an active E-rosette assay. Positive results occurred in IgAN and HSPN. It was suggested that delayed hypersensitivity to sulfatide may generate an autoimmune inflammatory process. It has been reported that laminin binds specifically to sulfatide. Autoimmunity to sulfatide may disturb the laminin binding and consequently interfere with renal function. These results suggested sulfatide antigen may play important role in occurrence and aggravation of glomerular disease.

    Topics: Adolescent; Autoimmunity; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Glomerulonephritis; Humans; Immunity, Cellular; Immunoglobulins; Male; Rosette Formation; Sulfoglycosphingolipids; T-Lymphocytes

1991